Pharmacogenetics: How Will This Change Asthma Management?

Clinical Asthma

Volumn , Issue , 2008, Pages 229-237

  Lima, John J ^a  

^a NEMOURS CHILDREN S CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 55649122533     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-032304289-5.10026-8     Document Type: Chapter

References (18)

1. ES Lander, LM Linton, B Birren, et al. (2001) Initial sequencing and analysis of the human genome. Nature 409 860-921.
2. JC Venter, MD Adams, EW Myers, et al. (2001) The sequence of the human genome. Science 291 1304-1351.
3. D Altshuler, LD Brooks, A Chakravarti, et al. (2005) A haplotype map of the human genome. Nature 437 1299-1320.
4. P Sebastiani, R Lazarus, ST Weiss, et al. (2003) Minimal haplotype tagging. Proc Natl Acad Sci USA 100 9900-9905.
5. KG Becker (2004) The common variants/multiple disease hypothesis of common complex genetic disorders. Med Hypotheses 62 309-317.
6. JN Hirschhorn and MJ Daly (2005) Genome-wide association studies for common diseases and complex traits. Nat Rev Genet 6 95-108.
7. WE Evans and HL McLeod (2003) Pharmacogenomics—drug disposition, drug targets, and side effects. N Engl J Med 348 538-549.
8. JM Drazen, EK Silverman and TH Lee (2000) Heterogeneity of therapeutic responses in asthma. Br Med Bull 56 1054-1070.
9. ST Weiss, ER Blecker and GA Hawkins (2005) Asthma pharmacogenetics. Immunol Allergy Clin North Am 25 723.
10. KG Tantisira and ST Weiss (2005) The pharmacogenetics of asthma an update. Curr Opin Mol Ther 7 209-217.
11. CM Drysdale, DW McGraw, CB Stack, et al. (2000) Complex promoter and coding region beta 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness. Proc Natl Acad Sci USA 97 10483-10488.
12. SB Liggett (1997) Polymorphisms of the beta2-adrenergic receptor and asthma. Am J Respir Crit Care Med 156 S156-S162.
13. FD Martinez, PE Graves, M Baldini, et al. (1997) Association between genetic polymorphisms of the beta2-adrenoceptor and response to albuterol in children with and without a history of wheezing. J Clin Invest 100 3184-3188.
14. JJ Lima, M Mohamed, LV Eberle, et al. (1999) Impact of genetic polymorphisms of the beta 2-adrenergic receptor on albuterol bronchodilator pharmacodynamics. Clin Pharmacol Ther 65 519-525.
15. E Israel, VM Chinchilli, JG Ford, et al. (2004) Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial. Lancet 364 1505-1512.
16. IM Adcock, K Ito and PJ Barnes (2004) Glucocorticoids: effects on gene transcription. Proc Am Thorac Soc 1 247-254.
17. JJ Lima, S Zhang, A Grant, et al. (2006) Influence of leukotriene pathway polymorphisms on response to montelukast in asthma. Am J Respir Crit Care Med 173 379-385.
18. ST Weiss, SL Lake, ES Silverman, et al. (2004) Asthma steroid pharmacogenetics: a study strategy to identify replicated treatment responses. Proc Am Thorac Soc 1 364-367.